The overexpression of PGC-1α in CD8 T cells consistently mediates immune responses in the setting of a bacterial infection or peptide vaccination, and CD8+ T cells with elevated PGC-1α expression have been observed in mouse cancer models to provide stronger antitumor immunity. This evidence concerns the gene PPARGC1A and cancer.